- Compare:
Chart data reflects last close values.
Companies in Biotechnology
| Symbol | Name | Mkt Cap | Last Price | Change | Member Sentiment |
|
|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories International, Inc. |
1.63B | $24.07 | -$0.75 | -3.02% | Buy |
| CRTX | Cornerstone Therapeutics Inc. |
117.00M | $2.70 | $0.14 | 5.47% | Neutral |
| CRXL | Crucell NV |
1.51B | $23.00 | $2.50 | 12.20% | Neutral |
| CRXX | CombinatoRx, Incorporated |
26.67M | $0.76 | -$0.02 | -2.56% | Neutral |
| CTICD | Cell Therapeutics, Inc. |
11.74M | $0.84 | $0.00 | 0.00% | Neutral |
| CUR | Neuralstem Inc |
49.83M | $1.55 | $0.02 | 1.31% | Neutral |
| CVM | CEL-SCI-Sci Corp |
35.35M | $0.30 | $0.02 | 7.14% | Neutral |
| CVTX | CV Therapeutics, Inc. |
572.18M | $9.33 | $0.10 | 1.08% | Neutral |
| CXM | Cardium Therapeutics Inc |
24.87M | $0.53 | -$0.07 | -11.67% | Neutral |
| CXSP | Chemgenex Pharmaceuticals Ltd |
131.10M | $10.51 | -$1.44 | -12.05% | Neutral |
| CYCC | Cyclacel Pharmaceuticals, Inc. |
8.97M | $0.44 | -$0.02 | -4.30% | Neutral |
| CYPB | Cypress Bioscience, Inc. |
292.46M | $7.72 | $0.09 | 1.18% | Neutral |
| CYTK | Cytokinetics, Incorporated |
140.42M | $2.84 | -$0.02 | -0.70% | Neutral |
| CYTO | Cytogen Corporation |
21.70M | $0.61 | $0.00 | 0.00% | Neutral |
| CYTR | CytRx Corporation |
26.15M | $0.28 | -$0.01 | -3.41% | Neutral |
| CYTX | Cytori Therapeutics Inc |
110.88M | $3.79 | $0.22 | 6.16% | Neutral |
| DARA | DARA Biosciences, Inc. |
14.16M | $0.48 | -$0.02 | -4.00% | Neutral |
| DNA | Genentech, Inc |
88.79B | $84.40 | -$0.13 | -0.15% | Neutral |
| DNDN | Dendreon Corporation |
431.39M | $4.45 | -$0.15 | -3.26% | Buy |
| DSCO | Discovery Laboratories, Inc. |
124.60M | $1.24 | $0.06 | 5.08% | Neutral |
| DYAX | Dyax Corp. |
228.49M | $3.63 | $0.10 | 2.83% | Neutral |
| EBS | Emergent BioSolutions Inc. |
767.78M | $25.66 | $0.06 | 0.23% | Neutral |
| ENCY | Encysive Pharmaceuticals Inc |
190.24M | $2.35 | $0.00 | 0.00% | Neutral |
| ENMD | EntreMed, Inc. |
19.52M | $0.22 | -$0.02 | -7.44% | Neutral |
| ENZN | Enzon Pharmaceuticals, Inc. |
277.36M | $6.17 | $0.26 | 4.40% | Neutral |
Biotechnology
Industry Performance
| Today | 1w | 1m | 3m | YTD | 1y | 5y |
|---|---|---|---|---|---|---|
| 0.65% | 1.35% | 8.40% | 10.65% | 0.62% | 23.18% | 128.48% |
Top Members in Biotechnology
-
Top 1%
+5.50%
-
Top 1%
+12.55%
-
Top 1%
+28.22%
* Average monthly return vs. S&P 500
Industry News
-
5 Biotech Stocks To Watch In 2009
Investopedia - Dec 30 2008 at 11:49 ET
-
Biotech Firm Hoping For Wider Approval Of Drug For Liver Cancer
Investor's Business Daily - Dec 12 2008 at 5:41 ET
-
Medicis shares higher after patent settlement over acne drug
CNNMoney.com - Dec 02 2008 at 12:35 ET
-
CTI chief learns hard lessons from merger
FT.com - Nov 21 2008 at 12:15 ET
-
Outlook for Small Cap Biotechnology Companies Discussed in Wall Street Transcript Report
Wall Street Transcript - Nov 19 2008 at 9:20 ET